30 Days of MarketBeat All Access for $1.00
Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more.
Start Your Risk-Free Trial Here

CGS Insider Trading (Cogstate)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$2,025,000.00

Cogstate Insider Trading History Chart

Cogstate Share Price & Price History

A$0.00
+0.30 (1.20%)
As of 05/13/2020 01:00 AM ET
Six Tech Stocks That Could Double
5G… blockchain… electric vehicles… There are enough tech opportunities out there to make your head spin! But which ones should you own for the coming tech boom?

Louis Navellier — the analyst who found Microsoft at .38 cents — just released a new report detailing six tech stocks to own today.

Don’t miss your chance to get his latest picks — ticker symbol and all — completely free of charge.
Click here to get your free report today.
pixel

Cogstate Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/23/2021Bradley O'ConnorInsiderExercise750,000A$0.84A$630,000.00
3/9/2021Bradley O'ConnorInsiderSell2,250,000A$0.90A$2,025,000.00
11/2/2020Bradley O'ConnorInsiderIssued1,250,000A$1.11A$1,387,500.00
3/13/2020Bradley O'ConnorInsiderBuy1,100,000A$0.21A$231,000.00
See Full Table
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations across various indications, including Alzheimer's disease, HIV, multiple sclerosis, pediatric and adult oncology, Parkinson's disease, epilepsy, and schizophrenia. As of June 30, 2020, it had participated in approximately 1,800 academic research studies in approximately 200 indications. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist in the early detection of cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is based in Fitzroy, Australia.
Read More on Cogstate

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

2,002 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Cogstate?

Cogstate's top insider investors include:
  1. Bradley O'Connor (Insider)
The 32-Second Options Trading "Training Video"
Watch his 32-second options trading "training video" here.
Continue Reading
pixel